Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome)
← catalyst calendarSponsored by Toray Industries, Inc (industry) · 3402.T — their whole pipeline →.
Phase
Not applicable
Status
Unknown status
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
45estimated
Sites
1
Country
Japan
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2021-05-22 | actual | When the study began enrolling |
| Primary completion | 2025-06-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-09-04 | estimated | The whole study's end, after follow-up |
| First posted | 2021-03-18 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-07-09 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Acute Respiratory Distress Syndrome
Intervention
- Device: NOA-001
Primary outcome
what the primary-completion date above is the date OFVentilator Free Days (VFD, Days alive and ventilator-free)
measured Day 28
Permalink · 3402.T's whole pipeline · Catalyst calendar · Every registered study · What changed